Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

BlueskyFacebookInstagram LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Contact Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST

Featured as Sponsored Programming: FLOKI, BioVie Inc. (NASDAQ: BIVI), NRX Pharmaceuticals (NASDAQ: NRXP), and Vita Bella

NEW YORK CITY, NEW YORK / ACCESS Newswire / June 16, 2025 / New to The Street, a premier financial media platform, announces the nationwide broadcast of Show #672 airing tonight at 10:30 PM EST on the Fox Business Network. This nationally televised episode features long-form interviews with four dynamic companies, offering investors a front-row seat to market-moving innovation and growth.

Featured companies on tonight's show include:

  • FLOKI - The popular Web3 ecosystem continues to lead with utility and community engagement. FLOKI's highly anticipated Valhalla metaverse game officially launches on June 30, marking a major milestone for the project's play-to-earn vision and cementing its role in the next generation of crypto gaming.

  • BioVie Inc. (NASDAQ: BIVI) - A clinical-stage biopharmaceutical innovator advancing treatments in neurodegenerative and liver diseases. With multiple Phase 3 trials underway, BioVie is positioned as a leader in the Alzheimer's and hepatology therapeutic categories.

  • NRX Pharmaceuticals (NASDAQ: NRXP) - A cutting-edge life sciences company developing novel therapies for treatment-resistant depression and pulmonary disorders. NRX's pipeline includes breakthrough-stage compounds with FDA fast-track designations and real-world impact potential.

  • Vita Bella - A rising name in health and lifestyle, Vita Bella delivers premium nutrition and wellness products tailored for modern consumers seeking vitality, beauty, and balance.

Each interview explores the companies' strategic goals, innovation roadmaps, and value propositions, offering clarity and visibility to investors across retail and institutional markets.

"Show #672 highlights the diversity of innovation happening across Web3, biotech, and wellness," said Vince Caruso, CEO and Creator of New to The Street. "With FLOKI's Valhalla launch on the horizon and biotech milestones accelerating, this lineup demonstrates how vision meets execution."

About New to The Street
New to The Street is one of the longest-running business television platforms in the U.S., delivering sponsored content and earned media since 2009. Weekly broadcasts on Fox Business Network and Bloomberg Television reach over 220 million households, supplemented by 2.65 million YouTube subscribers and a combined social media audience of over 700,000 followers across LinkedIn, Instagram, Facebook, and X. Its proprietary ecosystem integrates national TV exposure, digital reach, NYC outdoor billboards, and earned media pickups on ABC, NBC, and CBS affiliate networks.

Media Contact:
Monica Brennan
Public Relations - New to The Street
Monica@NewToTheStreet.com

SOURCE: New To The Street



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.